Use and Effectiveness of HIV Indicator Conditions in Guiding HIV Testing: A Review of the Evidence

References (48)

1. 1 Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE) [DOI]
2. 2 Use of laboratory tests and clinical symptoms for identification of primary HIV infection [DOI]
3. 3 HIV transmission rates from persons living with HIV who are aware and unaware of their infection [DOI]
4. 4 Feasibility and Effectiveness of Indicator Condition-Guided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study) [DOI]
5. 5 Prediction of HIV Acquisition Among Men Who Have Sex With Men [DOI]
6. 6 Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK [DOI]
7. 7 Review of Medical Encounters in the 5 Years Before a Diagnosis of HIV-1 Infection: Implications for Early Detection [DOI]
8. 8 Diagnosed and undiagnosed HIV‐infected populations in Europe [DOI]
9. 9 Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study [DOI]
10. 10 Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study [DOI]
11. 11 Late Diagnosis of HIV Infection: The Role of Age and Sex [DOI]
12. 12 Routine HIV Screening in France: Clinical Impact and Cost-Effectiveness [DOI]
13. 13 Routine human immunodeficiency virus testing: An economic evaluation of current guidelines [DOI]
14. 14 Missed opportunities for diagnosing primary HIV infection [DOI]
15. 15 Derivation and Validation of the Denver Human Immunodeficiency Virus (HIV) Risk Score for Targeted HIV Screening [DOI]
16. 16 Clinical presentation and diagnosis of primary HIV-1 infection [DOI]
17. 17 A System-wide Intervention to Improve HIV Testing in the Veterans Health Administration [DOI]
18. 18 Low levels of HIV test coverage in clinical settings in the UK: a systematic review of adherence to 2008 guidelines [DOI]
19. 19 Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto [DOI]
20. 20 Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel [DOI]
21. 21 Indicator disease‐guided testing for HIV – the next step for Europe? [DOI]
22. 22 HIV indicator condition-guided testing to reduce the number of undiagnosed patients and prevent late presentation in a high-prevalence area: a case–control study in primary care [DOI]
23. 23 Signs or Symptoms of Acute HIV Infection in a Cohort Undergoing Community-Based Screening [DOI]
24. 24 The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis [DOI]
25. 25 HIV diagnoses and missed opportunities. Results of the British HIV Association (BHIVA) National Audit 2010 [DOI]
26. 26 Missed opportunities for HIV testing of patients diagnosed with an indicator condition in primary care in Catalonia, Spain [DOI]
27. 27 Diagnosing HIV Infection in Primary Care Settings: Missed Opportunities [DOI]
28. 28 Trends in missed presentations and late HIV diagnosis in a UK teaching hospital: a retrospective comparative cohort study [DOI]
29. 29 Assessing the predictive value of HIV indicator conditions in general practice: a case–control study using the THIN database [DOI]
30. 30 Acute Human Immunodeficiency Virus Infection [DOI]
31. 31 Morbidity and Risk of Subsequent Diagnosis of HIV: A Population Based Case Control Study Identifying Indicator Diseases for HIV Infection [DOI]
32. 32 Development and Validation of an HIV Risk Exposure and Indicator Conditions Questionnaire to Support Targeted HIV Screening [DOI]
33. 33 Evaluation of the Sustainability of an Intervention to Increase HIV Testing [DOI]
34. 34 A feasibility study for a clinical decision support system prompting HIV testing [DOI]
35. 35 A Targeted, Conventional Assay, Emergency Department HIV Testing Program Integrated With Existing Clinical Procedures [DOI]
36. 36 HIV-indicator-condition-driven HIV testing: clinically effective but still rarely implemented [DOI]
37. 37 Associations of HIV testing and late diagnosis at a Japanese university hospital [DOI]
38. 38 Missed opportunities for HIV diagnosis: a three-year audit in the West of Scotland [DOI]
39. 39 Missing the mark: ongoing missed opportunities for HIV diagnosis at an urban medical center despite universal screening recommendations [DOI]
40. 40 Feasibility and acceptability of routine human immunodeficiency virus testing in general practice: your views [DOI]
41. 41 Five-year risk of HIV diagnosis subsequent to 147 hospital-based indicator diseases: a Danish nationwide population-based cohort study [DOI]
42. 42 Does general practice deliver safe primary care to people living with HIV? A case-notes review [DOI]
43. 43 Symptomatic Patients without Epidemiological Indicators of HIV Have a High Risk of Missed Diagnosis: A Multi-Centre Cross Sectional Study [DOI]
44. 44 The Development and Utility of a Clinical Algorithm to Predict Early HIV-1 Infection [DOI]
45. 45 Improving Human Immunodeficiency Virus Testing Rates with an Electronic Clinical Reminder [DOI]
46. 46 Expanded Screening for HIV in the United States—An Analysis of Cost-Effectiveness [DOI]
47. 47 Opportunities for earlier diagnosis of HIV in general practice [DOI]
48. 48 Late diagnosis of HIV infection: missed diagnostic opportunities [DOI]

Cited by 12

Showing 6 of 12 known citations — external sources report more than can currently be individually listed.

Related research

• Maternal Age and Congenital Anomalies among Newborns in a Tertiary Health Facility in Benue State, North Central Nigeria — shares topic coverage
• Early Diagnosis of Neonatal Sepsis: A Review of the Current Methods in Clinical Practice — shares topic coverage
• Skeletal Dysplasia: Approach to Simplify Diagnosis, Looking for Radiographic Clue Signs — shares topic coverage
• Impact of Radiology on the Early Identification of Waterhouse-friderichsen Syndrome: A Case Study — shares topic coverage
• The Impact of Genexpert MTB/RIF Technology on the Minimization of Tuberculosis: A Review of Literature — shares topic coverage